Clinical Trials Logo

Graft-versus-host Disease (GVHD) clinical trials

View clinical trials related to Graft-versus-host Disease (GVHD).

Filter by:
  • No longer available  
  • Page 1

NCT ID: NCT02026934 No longer available - Clinical trials for Delayed Graft Function

CliniMACS® CD34+ Reagent System for Expanded Access Use

Start date: March 2013
Phase: N/A
Study type: Expanded Access

CliniMACs is an investigational device used to select and enrich stem cells. The device will select the stem cells with CD34+ protein. The participant will be infused with the CD34+ selected cells in the hopes that it will help the participant engraft. Engraftment is when transplanted stem cells resume production of healthy blood cells.